Literature DB >> 20845400

Rectum-conserving surgery in the era of chemoradiotherapy.

F M Smith1, D Waldron, D C Winter.   

Abstract

BACKGROUND: A complete pathological response occurs in 10-30 per cent of patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy (CRT). The standard of care has been radical surgery with high morbidity risks and the challenges of stomata despite the favourable prognosis. This review assessed minimalist approaches (transanal excision or observation alone) to tumours with a response to CRT.
METHODS: A systematic review was performed using PubMed and Embase databases. Keywords included: 'rectal', 'cancer', 'transanal', 'conservative', 'complete pathological response', 'radiotherapy' and 'neoadjuvant'. Original articles from all relevant listings were sourced. These were hand searched for further articles of relevance. Main outcome measures assessed were rates of local recurrence and overall survival, and equivalence to radical surgery.
RESULTS: Purely conservative 'watch and wait' strategies after CRT are still controversial. Originally used for elderly patients or those who refused surgery, the data support transanal excision of rectal tumours showing a good response to CRT. A complete pathological response in the T stage (ypT0) indicates < 5 per cent risk of nodal metastases.
CONCLUSION: Rectal tumours showing an excellent response to CRT may be suitable for local excision, with equivalent outcomes to radical surgery. This approach should be the subject of prospective clinical trials in specialist centres.
Copyright © 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20845400     DOI: 10.1002/bjs.7251

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  35 in total

Review 1.  Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.

Authors:  Irshad Shaikh; Alan Askari; Suzana Ourû; Janindra Warusavitarne; Thanos Athanasiou; Omar Faiz
Journal:  Int J Colorectal Dis       Date:  2014-11-04       Impact factor: 2.571

Review 2.  Management of the Complete Clinical Response.

Authors:  Angelita Habr-Gama; Guilherme Pagin São Julião; Bruna Borba Vailati; Ivana Castro; Debora Raffaele
Journal:  Clin Colon Rectal Surg       Date:  2017-11-27

3.  Transanal Minimally Invasive Surgery (TAMIS): a clinical spotlight review.

Authors:  Teresa deBeche-Adams; Imran Hassan; Stephen Haggerty; Dimitrios Stefanidis
Journal:  Surg Endosc       Date:  2017-06-27       Impact factor: 4.584

4.  Genomic predictor of complete response after chemoradiotherapy in rectal cancer.

Authors:  Gyoung Tae Noh; Nam Kyu Kim
Journal:  Ann Transl Med       Date:  2016-12

Review 5.  Treatment of colorectal cancer in the elderly.

Authors:  Monica Millan; Sandra Merino; Aleidis Caro; Francesc Feliu; Jordi Escuder; Tani Francesch
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

6.  Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging.

Authors:  R O Perez; A Habr-Gama; G P São Julião; P B Lynn; C Sabbagh; I Proscurshim; F G Campos; J Gama-Rodrigues; S C Nahas; C A Buchpiguel
Journal:  Tech Coloproctol       Date:  2014-02-08       Impact factor: 3.781

7.  Assessment of a novel, full-thickness incisional biopsy model to restage rectal tumours after neoadjuvant chemoradiotherapy: results of an ex vivo pilot study.

Authors:  F M Smith; H Wiland; A Mace; R K Pai; M F Kalady
Journal:  Tech Coloproctol       Date:  2015-02-17       Impact factor: 3.781

Review 8.  Review of Neoadjuvant Chemotherapy Alone in Locally Advanced Rectal Cancer.

Authors:  Omer Jalil; Leica Claydon; Tan Arulampalam
Journal:  J Gastrointest Cancer       Date:  2015-09

9.  Transanal endoscopic microsurgery vs. laparoscopic total mesorectal excision for T2N0 rectal cancer.

Authors:  Marco Ettore Allaix; Alberto Arezzo; Giuseppe Giraudo; Mario Morino
Journal:  J Gastrointest Surg       Date:  2012-10-16       Impact factor: 3.452

Review 10.  Multidisciplinary treatment of rectal cancer in 2014: where are we going?

Authors:  Andrea Vignali; Paola De Nardi
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.